Timothy D Heath
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$503KFederal grants as PI4 awards
1Patents grantedLatest Aug 13, 2024
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
4 awards · $503K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 12, 2019 | NIH | SBIR Phase I A 3-month Release Naltrexone for Addiction Treatment | $20K | PLUMB PHARMACEUTICALS, INC |
| Jan 7, 2019 | NIH | SBIR Phase I A 3-month Release Naltrexone for Addiction Treatment | $55K | PLUMB PHARMACEUTICALS, INC |
| Aug 31, 2018 | NIH | SBIR Phase I A 3-month Release Naltrexone for Addiction Treatment | $203K | PLUMB PHARMACEUTICALS, INC |
| Jun 26, 2018 | NSF | SBIR Phase I SBIR Phase I: Refining a 3-month release buprenorphine, advancing a drug delivery platform | $225K | PLUMB PHARMACEUTICALS, INC |
2 patents as inventor
- US 12059499PLUMB PHARMACEUTICALS, INCAug 13, 2024
- US PLUMB PHARMACEUTICALS, INC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#2,402
Awards as PI#566
Patents#155
Companies
- PLUMB PHARMACEUTICALS, INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.